Spark Therapeutics: 3Q Earnings Snapshot

November 6, 2018

PHILADELPHIA (AP) _ Spark Therapeutics Inc. (ONCE) on Tuesday reported a loss of $47.4 million in its third quarter.

The Philadelphia-based company said it had a loss of $1.26 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.04 per share.

The gene therapy developer posted revenue of $10.7 million in the period, also falling short of Street forecasts. Seven analysts surveyed by Zacks expected $26.1 million.

Spark Therapeutics shares have dropped 14 percent since the beginning of the year. The stock has declined 46 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCE at https://www.zacks.com/ap/ONCE

Update hourly